Takeda pledges close to $765M for plasma-derived therapy production site in Japan esagonowsky Thu, 03/23/2023 – 16:33 More: Takeda pledges close to 5M for plasma-derived therapy production site in Japan Source: fierce
read moreEngland’s NICE signs off on PTC Therapeutics’ $3.7M gene therapy for ultra-rare disease zbecker Thu, 03/23/2023 – 13:47 More: England's NICE signs off on PTC Therapeutics' .7M gene therapy for ultra-rare disease Source: fierce
read moreNonprofit taps Catalent to help make dream of over-the-counter naloxone a reality fkansteiner Thu, 03/23/2023 – 12:46 More: Nonprofit taps Catalent to help make dream of over-the-counter naloxone a reality Source: fierce
read moreCidara gains first FDA approval, $20M milestone payment as FDA endorses Rezzayo kdunleavy Thu, 03/23/2023 – 10:51 More: Cidara gains first FDA approval, M milestone payment as FDA endorses Rezzayo Source: fierce
read moreAbbVie’s Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda aliu Thu, 03/23/2023 – 10:23 More: AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda Source: fierce
read moreThe partnership will involve progressing macrophage-targeting antibody treatment for cancer More: Ono and Macomics join forces to develop cancer therapy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals